SEC 13F Intelligence

Neville Rodie & Shaw Inc / JNJ

Neville Rodie & Shaw Inc’s Johnson & Johnson Position

Does Neville Rodie & Shaw Inc own Johnson & Johnson (JNJ)? Yes — 168.2K shares worth $43M (+2.76% of its 13F portfolio) as of Q2 2026, down from 169.9K shares the prior filed quarter.

Position Value
$43M
Q2 2026
Shares
168.2K
% of Portfolio
+2.76%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $33MQ4 ’18Q1 ’19: $36MQ2 ’19: $35MQ3 ’19: $33MQ4 ’19: $38MQ4 ’19Q1 ’20: $34MQ2 ’20: $36MQ3 ’20: $38MQ1 ’21: $41MQ1 ’21Q2 ’21: $41MQ3 ’21: $40MQ4 ’21: $42MQ1 ’22: $43MQ1 ’22Q2 ’22: $43MQ3 ’22: $39MQ4 ’22: $42MQ1 ’23: $36MQ1 ’23Q2 ’23: $38MQ3 ’23: $36MQ4 ’23: $35MQ1 ’24: $35MQ1 ’24Q2 ’24: $28MQ3 ’24: $29MQ4 ’24: $26MQ1 ’25: $29MQ1 ’25Q2 ’25: $26MQ3 ’25: $30MQ4 ’25: $34MQ1 ’26: $42MQ1 ’26Q2 ’26: $43Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026168.2K$43M+2.76%
Q1 2026169.9K$42M+3.02%
Q4 2025166.2K$34M+2.43%
Q3 2025162.7K$30M+2.18%
Q2 2025169.2K$26M+1.92%
Q1 2025172.1K$29M+2.23%
Q4 2024179.4K$26M+1.89%
Q3 2024180.8K$29M+2.16%
Q2 2024189.0K$28M+2.10%
Q1 2024220.1K$35M+2.66%
Q4 2023225.3K$35M+2.89%
Q3 2023229.1K$36M+3.18%
Q2 2023230.3K$38M+3.28%
Q1 2023233.4K$36M+3.28%
Q4 2022236.2K$42M+3.92%
Q3 2022236.1K$39M+3.79%
Q2 2022239.7K$43M+3.81%
Q1 2022242.0K$43M+3.21%
Q4 2021242.9K$42M+2.94%
Q3 2021245.7K$40M+3.08%
Q2 2021248.6K$41M+3.15%
Q1 2021248.7K$41M+3.39%
Q3 2020255.7K$38M+3.59%
Q2 2020255.1K$36M+3.71%
Q1 2020257.8K$34M+4.12%
Q4 2019259.1K$38M+3.71%
Q3 2019255.6K$33M+3.50%
Q2 2019249.3K$35M+3.68%
Q1 2019256.5K$36M+3.80%
Q4 2018258.9K$33M+4.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neville Rodie & Shaw Inc’s full portfolio or all institutional holders of JNJ.